Related content

Efficacy of telithromycin in community-acquired pneumonia caused by Legionella pneumophila

By Carbon C.   Nusrat R.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 8, 2004-08 ,pp. : 650-652

Springer Publishing Company

Access to resources Recommend Favorite

Full-Course Oral Levofloxacin for Treatment of Hospitalized Patients with Community-Acquired Pneumonia

By Erard V.   Lamy O.   Bochud P.-Y.   Bille J.   Cometta A.   Calandra T.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 2, 2004-02 ,pp. : 82-88

Springer Publishing Company

Access to resources Recommend Favorite

Severe adenovirus community-acquired pneumonia mimicking Legionella

By Cunha B.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 28, Iss. 3, 2009-03 ,pp. : 313-315

Springer Publishing Company

Access to resources Recommend Favorite

Antimicrobial activity of prulifloxacin in comparison with other fluoroquinolones against community-acquired urinary and respiratory pathogens isolated in Greece

By Karageorgopoulos D.   Maraki S.   Vatopoulos A.   Samonis G.   Schito G.   Falagas M.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 32, Iss. 11, 2013-11 ,pp. : 1417-1422

Springer Publishing Company

Access to resources Recommend Favorite

Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia

By Chokshi R.   Restrepo M.   Weeratunge N.   Frei C.   Anzueto A.   Mortensen E.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 7, 2007-07 ,pp. : 447-451

Springer Publishing Company

Access to resources Recommend Favorite